MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation…
DWP will give you extra £11,715 for 70 conditions – full list | Personal Finance | Finance
A little-known benefit could pay you as much as £11,715 a year from the DWP – and it’s…
Warning issued to anyone with a wood burner | UK | News
Many Brits are gearing up for the encroaching cold weather, getting excited about cosy nights reading by the fire. However,home…